Benzinga - Thu, 11 Feb 2021 05:04:36 -0400
Benzinga - Wed, 10 Feb 2021 14:06:17 -0400
Benzinga - Wed, 10 Feb 2021 11:23:13 -0400
Benzinga - Wed, 10 Feb 2021 08:00:26 -0400
Benzinga - Tue, 09 Feb 2021 07:56:45 -0400
Benzinga - Thu, 28 Jan 2021 13:00:35 -0400
Benzinga - Thu, 28 Jan 2021 09:08:16 -0400
Benzinga - Thu, 28 Jan 2021 08:06:40 -0400
Benzinga - Fri, 22 Jan 2021 18:04:20 -0400
Benzinga - Fri, 22 Jan 2021 05:54:13 -0400
Benzinga - Thu, 21 Jan 2021 13:01:09 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Acasti Pharma Inc is a biopharmaceutical innovator advancing a cardiovascular drug, CaPre (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the U.S. population. The company is focused on addressing a critical market need for an effective, safe and well-absorbing omega-3 therapeutic that can make a positive impact on the blood lipids associated with cardiovascular disease risk. The Company is developing CaPre in a Phase 3 clinical program in patients with severe hypertriglyceridemia.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS-0.030
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ACSTAcasti Pharma12.49%113.2M

Acasti Pharma Company Questions & Answers

Q

How do I buy Acasti Pharma (ACST) stock?

A

You can purchase shares of Acasti Pharma (NASDAQ: ACST) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acasti Pharma's (ACST) main competitors?

A

Other companies in Acasti Pharma’s space includes: Opiant Pharmaceuticals (NASDAQ:OPNT), Baudax Bio (NASDAQ:BXRX) and Cocrystal Pharma (NASDAQ:COCP).

Q

What is the target price for Acasti Pharma?

A

The latest price target for Acasti Pharma (NASDAQ: ACST) was reported by Aegis Capital on 2020-09-02. The analyst firm set a price target for 0.25 expecting ACST to fall to within 12 months (a possible -60.34% downside). 5 analyst firms have reported ratings in the last year.

Q

How much is Acasti Pharma (ACST) stock ?

A

The stock price for Acasti Pharma (NASDAQ: ACST) is $0.6304 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Acasti Pharma (ACST) dividend?

A

There are no upcoming dividends for Acasti Pharma.

Q

When is Acasti Pharma (NASDAQ:ACST) reporting earnings?

A
Acasti Pharma’s Q3 earnings are confirmed from now on February 9, 2021.
Q

When is the upcoming split for ACST?

A

There is no upcoming split for Acasti Pharma.